NCT00790322View on ClinicalTrials.gov

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Head and Neck CancerOral Mucositis
Interventions
DRUG

SBG

Soluble beta-1,3/1,6-glucan is a solution for oral use

OTHER

Placebo

Solution for oral use

Trial Locations (1)

94805

Institute Gustave Roussy, Villejuif Cédex

Sponsors
All Listed Sponsors
lead

Biotec Pharmacon ASA

INDUSTRY

NCT00790322 - Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy | Biotech Hunter | Biotech Hunter